, 23 July 2024

Transforming CPG: What is the debate around Ultra-Processed Foods?

In this episode of Transforming CPG, Managing Partner of Sevendots, Andrea Bielli, and Senior Partner Colin McAllister discuss what you need to know about the debate around Ultra-Processed Foods.

< 1 minute read

In this episode of Transforming CPG, Managing Partner of Sevendots, Andrea Bielli, and Senior Partner Colin McAllister discuss what you need to know about the debate around Ultra-Processed Foods. They cover…

  • The key studies emerging regarding UPF and health
  • Consumer concerns and awareness of the topic
  • How the industry is grappling with this emerging debate
  • Ways brand owners might better solve the problems UPFs have tried to solve in the past

…and much more.

Read more on UPFs and managing the risks in our latest article here: ⁠Ultra-Processed Food: What’s the debate and risks to health?⁠

Listen here:

Did you enjoy this podcast? Give us a rating and subscribe to receive new episodes as they are published. 

This podcast episode is here to showcase our thought leaders, but we’d also love to hear from you. Let us know your thoughts on the discussion and connect with us on ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠.

Related Articles

05 December 2023

Our November Roundup: greedflation, a free non-exclusive license from Unilever and the end of categories.

In this roundup, we discuss the end of categories, the possible impacts of Unilever's free non-exclusive license for 12 of its reformulation patents, Hotel Chocolat's new bar with 100% of sales to growers, and 'greedflation'.

, 25 January 2025

The “Ripple Effect”: Why Ozempic’s Impact on the CPG Industry is a Slow-Burning Disruption

GLP-1s – originally intended to treat diabetes, are designed to mimic the way a hormone called glucagon-like peptide 1 works... View Article

Colin McAllister

Sevendots, Milan

Gabrielle Carruthers

Sevendots, London